BACKGROUND: We determined the prevalence of urethral Mycoplasma genitalium (MG) infection and whether infection was associated with circumcision status among men enrolled in the randomized trial of medical male circumcision to prevent HIV acquisition in Kisumu, Kenya. METHODS:MG and Trichomonas vaginalis were detected in first void urine by APTIMA transcription-mediated amplification assay. first void urine and urethral swabs were assessed for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) by polymerase chain reaction assay. Herpes simplex virus type 2 antibodies were detected by IgG ELISA. Multivariable logistic regression identified factors associated with MG infection. RESULTS: Specimens were collected between July and September 2010, and 52 (9.9%; 95% confidence interval [CI]: 7.3%-12.4%) MG infections were detected among 526 men. N. gonorrhoeae and T. vaginalis were not associated with MG. CT coinfection was 5.8% in MG-infected men, and 0.8% among MG-uninfected men (P = 0.02). MG infection was predominantly asymptomatic (98%). The prevalence of MG was 13.4% in uncircumcised men versus 8.2% in circumcised men (P = 0.06). Being circumcised nearly halved the odds of MG (adjusted odds ratio [aQR] = 0.54; 95% CI: 0.29-0.99), adjusted for other variables significant at the P < 0.05 level: herpes simplex virus type 2 infection (aOR = 2.05; 95% CI: 1.05-4.00), CT infection (aOR = 2.69; 95% CI: 1.44-5.02), and washing the penis ≤1 hour after sex (aOR = 0.47; 95% CI: 0.24-0.95). CONCLUSIONS:MG infection was reduced among men who were circumcised, adding to the benefits of male circumcision in preventing several sexually transmitted infections.
RCT Entities:
BACKGROUND: We determined the prevalence of urethral Mycoplasma genitalium (MG) infection and whether infection was associated with circumcision status among men enrolled in the randomized trial of medical male circumcision to prevent HIV acquisition in Kisumu, Kenya. METHODS:MG and Trichomonas vaginalis were detected in first void urine by APTIMA transcription-mediated amplification assay. first void urine and urethral swabs were assessed for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) by polymerase chain reaction assay. Herpes simplex virus type 2 antibodies were detected by IgG ELISA. Multivariable logistic regression identified factors associated with MG infection. RESULTS: Specimens were collected between July and September 2010, and 52 (9.9%; 95% confidence interval [CI]: 7.3%-12.4%) MG infections were detected among 526 men. N. gonorrhoeae and T. vaginalis were not associated with MG. CT coinfection was 5.8% in MG-infected men, and 0.8% among MG-uninfected men (P = 0.02). MG infection was predominantly asymptomatic (98%). The prevalence of MG was 13.4% in uncircumcised men versus 8.2% in circumcised men (P = 0.06). Being circumcised nearly halved the odds of MG (adjusted odds ratio [aQR] = 0.54; 95% CI: 0.29-0.99), adjusted for other variables significant at the P < 0.05 level: herpes simplex virus type 2infection (aOR = 2.05; 95% CI: 1.05-4.00), CTinfection (aOR = 2.69; 95% CI: 1.44-5.02), and washing the penis ≤1 hour after sex (aOR = 0.47; 95% CI: 0.24-0.95). CONCLUSIONS:MG infection was reduced among men who were circumcised, adding to the benefits of male circumcision in preventing several sexually transmitted infections.
Authors: Sakhile Mhlongo; Precious Magooa; Etienne E Müller; Noel Nel; Frans Radebe; Elizabeth Wasserman; David A Lewis Journal: Sex Transm Dis Date: 2010-09 Impact factor: 2.830
Authors: F Månsson; C Camara; A Biai; M Monteiro; Z J da Silva; F Dias; A Alves; S Andersson; E M Fenyö; H Norrgren; M Unemo Journal: Int J STD AIDS Date: 2010-09 Impact factor: 1.359
Authors: Maria J Wawer; Aaron A R Tobian; Godfrey Kigozi; Xiangrong Kong; Patti E Gravitt; David Serwadda; Fred Nalugoda; Frederick Makumbi; Victor Ssempiija; Nelson Sewankambo; Stephen Watya; Kevin P Eaton; Amy E Oliver; Michael Z Chen; Steven J Reynolds; Thomas C Quinn; Ronald H Gray Journal: Lancet Date: 2011-01-06 Impact factor: 79.321
Authors: Jason Bailey Reed; Emmanuel Njeuhmeli; Anne Goldzier Thomas; Melanie C Bacon; Robert Bailey; Peter Cherutich; Kelly Curran; Kim Dickson; Tim Farley; Catherine Hankins; Karin Hatzold; Jessica Justman; Zebedee Mwandi; Luke Nkinsi; Renee Ridzon; Caroline Ryan; Naomi Bock Journal: J Acquir Immune Defic Syndr Date: 2012-08-15 Impact factor: 3.731
Authors: Aaron A R Tobian; Charlotte Gaydos; Ronald H Gray; Godfrey Kigozi; David Serwadda; Nicole Quinn; Mary K Grabowski; Richard Musoke; Anthony Ndyanabo; Fred Nalugoda; Maria J Wawer; Thomas C Quinn Journal: Sex Transm Infect Date: 2013-11-20 Impact factor: 3.519
Authors: Jillian Pintye; Jared M Baeten; Lisa E Manhart; Connie Celum; Allan Ronald; Nelly Mugo; Andrew Mujugira; Craig Cohen; Edwin Were; Elizabeth Bukusi; James Kiarie; Renee Heffron Journal: Lancet Glob Health Date: 2014-10-22 Impact factor: 26.763